WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004009586) NOVEL PIPERAZINYL-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF 5-HT2A RECEPTOR-RELATED DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/009586    International Application No.:    PCT/SE2003/001102
Publication Date: 29.01.2004 International Filing Date: 25.06.2003
Chapter 2 Demand Filed:    28.01.2004    
IPC:
C07D 241/20 (2006.01), C07D 241/44 (2006.01), C07D 403/06 (2006.01), C07D 403/12 (2006.01), C07D 405/12 (2006.01), C07D 409/06 (2006.01), C07D 409/12 (2006.01), C07D 411/12 (2006.01), C07D 413/12 (2006.01), C07D 487/04 (2006.01)
Applicants: BIOVITRUM AB [SE/SE]; Lindhagensgatan 133, S-112 76 Stockholm (SE) (For All Designated States Except US).
NILSSON, Björn [SE/SE]; (SE) (For US Only).
THOR, Markus [SE/SE]; (SE) (For US Only).
CERNERUD, Magnus [SE/SE]; (SE) (For US Only).
LUNDSTRÖM, Helena [SE/SE]; (SE) (For US Only)
Inventors: NILSSON, Björn; (SE).
THOR, Markus; (SE).
CERNERUD, Magnus; (SE).
LUNDSTRÖM, Helena; (SE)
Agent: CONRADI, Magnus; Biovitrum AB, S-112 76 Stockholm (SE)
Priority Data:
0202287-9 19.07.2002 SE
60/426,240 14.11.2002 US
Title (EN) NOVEL PIPERAZINYL-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF 5-HT2A RECEPTOR-RELATED DISORDERS
(FR) NOUVEAUX DERIVES DE PIPERAZINYL-PYRAZINONE POUR LE TRAITEMENT DES TROUBLES LIES AU RECEPTEUR 5-HT2A
Abstract: front page image
(EN)Compounds of the general formula (I): (I)wherein m, n, R1, R2, R3 and R4 are as described in the specification. Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament for the treatment of 5-HT2A receptor-related disorders or medical conditions.
(FR)La présente invention concerne des composés de la formule générale (1) dans laquelle m, n, R1, R2, R3 et R4 sont tels que définis dans le descriptif. L'invention se rapporte également à des compositions pharmaceutiques comprenant lesdits composés, à des procédés de préparation de ces derniers, et à l'utilisation desdits composés dans la préparation d'un médicament destiné au traitement des troubles ou états médicaux liés au récepteur 5-HT2A.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)